Opus Genetics Inc (IRD)
1.065
-0.02
(-2.29%)
USD |
NASDAQ |
Nov 14, 16:00
1.11
+0.04
(+4.23%)
After-Hours: 18:40
Opus Genetics Enterprise Value: -12.86M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -12.86M |
| November 12, 2024 | -11.55M |
| November 11, 2024 | -10.76M |
| November 08, 2024 | -12.07M |
| November 07, 2024 | -12.86M |
| November 06, 2024 | -10.76M |
| November 05, 2024 | -10.89M |
| November 04, 2024 | -10.76M |
| November 01, 2024 | -10.50M |
| October 31, 2024 | -9.976M |
| October 30, 2024 | -8.666M |
| October 29, 2024 | -6.570M |
| October 28, 2024 | -6.046M |
| October 25, 2024 | -10.76M |
| October 24, 2024 | -11.81M |
| October 23, 2024 | -10.76M |
| October 22, 2024 | -6.570M |
| October 21, 2024 | -6.570M |
| October 18, 2024 | -6.832M |
| October 17, 2024 | -8.142M |
| October 16, 2024 | -7.88M |
| October 15, 2024 | -8.666M |
| October 14, 2024 | -8.666M |
| October 11, 2024 | -9.452M |
| October 10, 2024 | -9.19M |
| Date | Value |
|---|---|
| October 09, 2024 | -8.142M |
| October 08, 2024 | -7.618M |
| October 07, 2024 | -8.142M |
| October 04, 2024 | -6.832M |
| October 03, 2024 | -7.618M |
| October 02, 2024 | -6.570M |
| October 01, 2024 | -8.404M |
| September 30, 2024 | -7.094M |
| September 27, 2024 | -7.618M |
| September 26, 2024 | -7.356M |
| September 25, 2024 | -7.618M |
| September 24, 2024 | -5.522M |
| September 23, 2024 | -5.784M |
| September 20, 2024 | -4.998M |
| September 19, 2024 | -3.295M |
| September 18, 2024 | -6.570M |
| September 17, 2024 | -7.094M |
| September 16, 2024 | -7.356M |
| September 13, 2024 | -7.356M |
| September 12, 2024 | -8.404M |
| September 11, 2024 | -7.356M |
| September 10, 2024 | -7.618M |
| September 09, 2024 | -9.714M |
| September 06, 2024 | -9.976M |
| September 05, 2024 | -8.928M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.86M
Minimum
Nov 07 2024
128.45M
Maximum
Feb 03 2021
34.43M
Average
35.90M
Median
Feb 14 2022
Enterprise Value Benchmarks
| Baxter International Inc | 27.52B |
| Syros Pharmaceuticals Inc | -7.537M |
| Elanco Animal Health Inc | 10.88B |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.765M |
| Revenue (Quarterly) | 1.112M |
| Total Expenses (Quarterly) | 9.44M |
| EPS Diluted (Quarterly) | -0.30 |
| Profit Margin (Quarterly) | -698.3% |
| Earnings Yield | -51.64% |
| Normalized Earnings Yield | -51.98 |